Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy

BACKGROUND: Lysophosphatidic acid (LPA) and lysophosphatidylcholine (LPC) are bioactive lysophospholipids involved in the pathogenesis of renal diseases, especially the renal fibrosis. Plasma LPC concentrations in chronic kidney disease (CKD) patients are lower or similar to those observed in contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalczyk, Anna, Dołęgowska, Barbara, Heryć, Rafał, Chlubek, Dariusz, Safranow, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449907/
https://www.ncbi.nlm.nih.gov/pubmed/30947711
http://dx.doi.org/10.1186/s12944-019-1040-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449907/
https://www.ncbi.nlm.nih.gov/pubmed/30947711
http://dx.doi.org/10.1186/s12944-019-1040-5

Ejemplares similares